Literature DB >> 31443090

Omentin, vaspin and irisin in chronic liver diseases.

M Waluga1, M Kukla2, R Kotulski3, M Zorniak2, G Boryczka2, M Kajor4, M Ciupinska-Kajor4, A Lekstan5, P Olczyk6, E Waluga6.   

Abstract

Omentin and vaspin are adipokines potentially considered in the development of liver pathology. Irisin is new myokin potentially participating in energy processes in the organisms. The aim of this study was to evaluate the plasma concentration of these cytokines and the relationships of them with selected parameters of laboratory tests and of histopathological changes in selected chronic liver diseases: non-alcoholic fatty liver diseases (NAFLD), primary biliary cholangitis (PBC) and alcoholic cirrhosis (AC). The plasma concentration of omentin was the highest in AC group and the lowest in control group (CG). Irisin plasma concentration was the highest in CG and the lowest in AC. Mean vaspin concentrations did not differ significantly between groups. Among many laboratory parameters, only in the AC group positive relationships were found between omentin concentration and bilirubin, as well as glucose, and negative between omentin level and the number of platelets and erythrocytes; there was a positive relationship between the concentration of vaspin and bilirubin, as well as negative between vaspin level and the number of erythrocytes or hematocrit value in this group. INR value had positive correlation with vaspin concentration and negative with irisin level in NAFLD group. No significant dependences between the concentrations of explored cytokines and laboratory tests were found in PBC group. It was found the positive correlation between the plasma concentration of irisin and fibrosis as well as inflammation in PBC group. The negative correlation between irisin level and inflammation in NAFLD was also showed. Omentin can be considered as an indicator for predicting inflammation, steatosis and balloon degeneration in NAFLD and PBC. Summarizing, it is unclear but possible that explored cytokines have some relationships with certain features of liver damage and development of chronic diseases of this organ.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31443090     DOI: 10.26402/jpp.2019.2.11

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  8 in total

Review 1.  Association of circulating vaspin levels and patients with metabolic-associated fatty liver disease: a systematic review and meta-analysis.

Authors:  Yuqing Zhu; Yani Ke; Yijie Hu; Kaihan Wu; Shan Liu; Jie Hu
Journal:  Lipids Health Dis       Date:  2022-07-02       Impact factor: 4.315

Review 2.  Chronic Inflammation-A Link between Nonalcoholic Fatty Liver Disease (NAFLD) and Dysfunctional Adipose Tissue.

Authors:  Maria Petrescu; Sonia Irina Vlaicu; Lorena Ciumărnean; Mircea Vasile Milaciu; Codruța Mărginean; Mira Florea; Ștefan Cristian Vesa; Monica Popa
Journal:  Medicina (Kaunas)       Date:  2022-05-06       Impact factor: 2.948

Review 3.  Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications.

Authors:  Doris Ogresta; Anna Mrzljak; Maja Cigrovski Berkovic; Ines Bilic-Curcic; Sanja Stojsavljevic-Shapeski; Lucija Virovic-Jukic
Journal:  J Clin Transl Hepatol       Date:  2022-01-12

Review 4.  Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?

Authors:  Vera Francisco; Maria Jesus Sanz; José T Real; Patrice Marques; Maurizio Capuozzo; Djedjiga Ait Eldjoudi; Oreste Gualillo
Journal:  Biology (Basel)       Date:  2022-08-19

5.  Irisin: Still chasing shadows.

Authors:  Elke Albrecht; Lisa Schering; Friedrich Buck; Konrad Vlach; Hans-Christof Schober; Christian A Drevon; Steffen Maak
Journal:  Mol Metab       Date:  2020-01-31       Impact factor: 7.422

Review 6.  Physiopathology of Lifestyle Interventions in Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  David Carneros; Guillermo López-Lluch; Matilde Bustos
Journal:  Nutrients       Date:  2020-11-12       Impact factor: 5.717

7.  Association between serum irisin concentrations and sarcopenia in patients with liver cirrhosis: a cross-sectional study.

Authors:  Mingyuan Zhao; Xiaoshuang Zhou; Chengying Yuan; Rongshan Li; Yuehong Ma; Xiaoxian Tang
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

Review 8.  The Potential Role of Irisin in Vascular Function and Atherosclerosis: A Review.

Authors:  Kyeongho Byun; Sewon Lee
Journal:  Int J Mol Sci       Date:  2020-09-29       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.